Dynorphin-(1-13), an extraordinarily potent opioid peptide - Wikidata - wikimedia - TriplyDB

Dynorphin-(1-13), an extraordinarily potent opioid peptide

Dynorphin-(1-13), an extraordinarily potent opioid peptide

http://www.wikidata.org/entity/Q24561638

about

Developmental potential for endomorphin opioidmimetic drugs Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist Immunoreactive dynorphin in pituitary and brain Kappa opioids as potential treatments for stimulant dependence Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin 15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse Dynorphin--still an extraordinarily potent opioid peptide κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction Current research on opioid receptor function.Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice A genetic polymorphism of the endogenous opioid dynorphin modulates monetary reward anticipation in the corticostriatal loop Effects of acute ethanol on corticotropin-releasing hormone and β-endorphin systems at the level of the rat central amygdala Endogenous Opioids: The Downside of Opposing Stress.Endogenous opioids: opposing stress with a cost.30 years of dynorphins--new insights on their functions in neuropsychiatric diseases Solution structure of dynorphin A (1-17): a NMR study in a cryoprotective solvent mixture at 278 K.Solution structure of human beta-endorphin in helicogenic solvents: an NMR study.A study of peptide--peptide interaction by matrix-assisted laser desorption/ionization.Cloning and characterization of Xen-dorphin prohormone from Xenopus laevis: a new opioid-like prohormone distinct from proenkephalin and prodynorphin.The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.Mu opioid receptors in pain management."DAKLI": a multipurpose ligand with high affinity and selectivity for dynorphin (kappa opioid) binding sites Biomarker discovery and clinical proteomics.Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture Stabilized dynorphin derivatives for modulating antinociceptive activity in morphine tolerant rats: effect of different routes of administration.Opioids and their receptors: Are we there yet?Influence of morphine on the distal oesophagus and the lower oesophageal sphincter--a manometric study.The kappa opioid receptor: from addiction to depression, and back.Pathobiology of dynorphins in trauma and disease.Can biomarkers differentiate pain and no pain subgroups of nonverbal children with cerebral palsy? A preliminary investigation based on noninvasive saliva sampling.Dmt and opioid peptides: a potent alliance.Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor.Opioid receptors and their pharmacological profiles.Two adrenal opioid polypeptides: proposed intermediates in the processing of proenkephalin.A highly potent 3200-dalton adrenal opioid peptide that contains both a [Met]- and [Leu]enkephalin sequence Dynorphin immunocytochemical localization in brain and peripheral nervous system: preliminary studies.Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats.Partial characterization of the mRNA that codes for enkephalins in bovine adrenal medulla and human pheochromocytoma.

P2860

Q21284990-077480C8-A291-4CD7-81D6-FE39A817EB01 Q24535736-54EC13F6-4FB9-4765-92CF-13964145CE3D Q24609641-ECCB9E8F-F297-481E-9A66-33A3C1BF05CF Q24647849-F369C60F-3CBC-4CD3-BD2F-C7C945AB83EC Q24681130-E5D7F2A0-B04F-4C89-AFD1-67D3ACE6EBCE Q26824667-F0AABDD2-AF6A-411E-BB5D-0573202FF93C Q26860519-92565D03-1C3D-4102-B463-57F3A2866198 Q26864309-4A1E2FEC-7EDB-4485-9552-68B449477910 Q27693220-D342A389-7810-4020-9911-ADC076CC43EE Q28363126-F1F1B49F-690F-4F23-92C8-55FED3711F86 Q28540133-CAE36520-B26D-483C-92A8-6707205FADF6 Q28572318-BCFC80B0-FBDF-431F-9DD3-4A9D5C0694DA Q30394985-18E100FA-22B8-40CB-B3F2-EC8BF7EB100E Q30408911-1B939B09-F08D-4A40-B69B-259A414B0FF0 Q30481450-7B564C56-1313-4977-A1D8-7ED5FD146EA0 Q30580552-0BC5AEEF-4899-48BF-9D49-06DE978BB2C1 Q30582829-AA10FE49-E5BA-4EA5-AE4F-E329D48AB3EB Q30643160-733561D6-5065-43A7-97D8-45FD7706DAC7 Q30744891-42513FFB-2325-44E1-97D7-760DDAE75980 Q33455500-96C2C802-4C3D-4F28-8B78-33386599B35B Q33581970-601AEC78-A53B-4B2F-AE29-580115F823C8 Q33652922-09992959-B743-46CC-98EC-6482D7D3FFE0 Q33655101-C2A4FF3C-0839-4232-846B-6E7FBD4B99D8 Q33921068-E9D82B3D-6793-4333-BD7C-888B8D09A4C9 Q34335745-BCB4A1C9-73D0-475D-8B27-CC58D7D69B60 Q34401808-1B5ED5BD-EDB6-43C0-B448-1141CDE3FA03 Q34437456-A366E369-6753-4158-85C9-FE0548E050BF Q34527070-8688012D-A270-47D6-9CE0-4BD7EB6975C8 Q34650892-B0A2A4D2-D0CE-4586-9D55-A4B5E011A374 Q35007416-8308D01D-3DE0-4BF8-BC08-E7DF2EF6A38B Q35096186-A0E61996-AA5B-4C2D-A123-57FB580EB664 Q35136105-0BD393C8-4247-4CFA-BB04-46F2E73A1208 Q35196966-0C221874-8E39-4EA3-BCA4-88DBFF355B02 Q35232070-24AB14A9-2D5F-42BB-89AC-CA6E7BCB1530 Q35336636-7E6E5A4F-3127-4B3F-A546-FE6B298EBE5F Q35369350-B19968A6-024A-432F-907C-0F2DD03D07A6 Q35428154-6EA667D3-B92C-4568-B634-98425134F47F Q35768240-EB2617B2-FF59-4243-BE7E-FC9F16CFAB32 Q35966430-FBEA08BD-CD1D-4336-B985-E6F59BA1C328 Q36276704-68C81DA8-8E89-406F-A7A3-E86B4C649237

P2860

Dynorphin-(1-13), an extraordinarily potent opioid peptide

http://www.wikidata.org/entity/Q24561638

description

1979 nî lūn-bûn

@nan

1979 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1979 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1979年の論文

@ja

1979年論文

@yue

1979年論文

@zh-hant

1979年論文

@zh-hk

1979年論文

@zh-mo

1979年論文

@zh-tw

1979年论文

@wuu

name

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@ast

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@en

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@nl

type

label

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@ast

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@en

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@nl

prefLabel

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@ast

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@en

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@nl

P1433

Q24561638-56D78923-F0BD-4958-A5B4-548CC306B596

P1476

Q24561638-4E00A59F-1D49-41E5-AD8E-0F22D0FCE50B

P2093

Q24561638-3201124B-B065-41F3-B355-38FA2B9FDA16

Q24561638-4522E93F-BED0-45FC-866E-C81B2270C605

Q24561638-B4E98E15-7070-4376-9C11-E1B8256F0C4C

Q24561638-EAC8A153-B8CE-48CA-9037-A4F8C01E5261

Q24561638-FD3F2A55-E898-4586-BE3F-B269B6BB357E

P2860

Q24561638-0776AE87-472A-45D7-9ED4-157DE307E8AC

Q24561638-1930ED9A-6B80-4B29-A398-E6BFE87E79F9

Q24561638-37A47B80-C4C6-4380-A639-2862761DE450

Q24561638-4A8A2108-3C78-4CA2-A357-493DED3156E4

Q24561638-5782CF62-E2A9-4D45-A985-A71B229FB24E

Q24561638-57A40411-E0F4-400A-AAA2-144AB9042861

Q24561638-5B0D3DA9-BF0B-4916-BD12-63CA6E594F82

Q24561638-64036542-15C7-4A46-A90E-4165172FC006

Q24561638-74798609-16EA-47BD-AC2D-5FAF83330383

Q24561638-832B3BD0-B0F0-401E-BFA4-1DAB08959B25

P304

Q24561638-90880B13-FA05-4177-9CC3-5BD5AC7F58F8

P31

Q24561638-33E15178-4640-40D6-A297-397116796405

P356

Q24561638-F9AAC150-2B31-441F-BC80-94F16748BE7F

P407

Q24561638-A8AD9BE2-A5EC-4D84-A126-53C9DB8D08AA

P433

Q24561638-DCA278E6-FD51-4BA2-AD20-CF352AC11B9D

P478

Q24561638-A9C73AD8-2AC0-4C28-B8BE-D7806B638C7D

P577

Q24561638-EFE846B9-987E-4804-A41C-02BCDBA33DAC

P5875

Q24561638-7F8DEB40-E4C3-40D1-AF2D-5A66364EA2D9

P698

Q24561638-56882B15-3FB4-4E86-8375-638A40FC6FAC

P921

Q24561638-04719d3d-609d-40e6-a2a7-850c95bd3286

Q24561638-ed7854b9-947c-4af0-aba1-72611176167d

P932

Q24561638-DD76F122-B50A-476F-BAD4-133B15EB0F9B

P356

PNAS.76.12.6666

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Dynorphin-(1-13), an extraordinarily potent opioid peptide

@en

P2093

A Goldstein

http://www.w3.org/2001/XMLSchema#string

L Hood

http://www.w3.org/2001/XMLSchema#string

L I Lowney

http://www.w3.org/2001/XMLSchema#string

M Hunkapiller

http://www.w3.org/2001/XMLSchema#string

S Tachibana

http://www.w3.org/2001/XMLSchema#string

P2860

(D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic

Preparation of iodine-131 labelled human growth hormone of high specific activity

Endogenous opioid peptides: multiple agonists and receptors.

Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics

Morphine-tolerant longitudinal muscle strip from guinea-pig ileum

Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides.

In vitro models in the study of structure-activity relationships of narcotic analgesics.

beta-Endorphin: structure-activity relationships in the guinea pig ileum and opiate receptor binding assays.

Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.

A pituitary endorphin with novel properties.

P304

6666-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.76.12.6666

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

1979-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

22906010

http://www.w3.org/2001/XMLSchema#string

P698

230519

http://www.w3.org/2001/XMLSchema#string

P921

P932

411929

http://www.w3.org/2001/XMLSchema#string